Recent Insights Into Circulating Adipokines in Obesity: Systematic Review and Meta‐Analysis
Authors:
- Sunita SunitaSSSunita Sunita
- Mohammad GhozaliMGMohammad Ghozali
- Mohammad Rizki AkbarMAMohammad Rizki Akbar
- Annisa Dewi NugrahaniANAnnisa Dewi Nugrahani
- Iis Inayati RakhmatIRIis Inayati Rakhmat
- Siti Nur FatimahSFSiti Nur Fatimah
- Yuni Susanti PratiwiYPYuni Susanti Pratiwi
- Eko Fuji AriyantoEAEko Fuji Ariyanto
- Gaga Irawan NugrahaGNGaga Irawan Nugraha
- Mas Rizky A. A. SyamsunarnoMSMas Rizky A. A. Syamsunarno
- Tri Hanggono AchmadTATri Hanggono Achmad
Open Access
- 21 January 2026
- journal article
- review article
- Published by Wiley in Obesity Science & Practice
- Vol. 12 (1)
Abstract
Background: Adipokines are dysregulated in obesity and exacerbate proinflammatory conditions. Although several studies have investigated adipokine levels in obesity, their findings have been inconsistent, leaving the precise nature of these alterations uncertain. This systematic review and meta‐analysis aimed to provide an updated overview of circulating adipokines, particularly adiponectin, leptin, fibroblast growth factor 21 (FGF21), growth differentiation factor 15 (GDF15), interleukin‐6 (IL‐6), and tumor necrosis factor‐α (TNF‐α) in the context of obesity. Methods: This study adhered to the Preferred Reporting Items for Systematic Reviews and Meta‐Analyses guidelines and PROSPERO registration (CRD42024525103). PubMed/MEDLINE, Scopus, and Journal of Clinical Investigation databases were searched from inception to August 25, 2025. Eligible observational studies were assessed using the ROBINS‐I and GRADE frameworks. Standardized mean differences (SMDs) were calculated using a random‐effects model. Results: From 2378 records, 30 and 16 studies were included in the review and meta‐analysis, respectively. Adiponectin levels were significantly lower in persons with obesity than in those with normal weight ( p = 0.007). Conversely, leptin, TNF‐α, and FGF21 levels were significantly higher in persons with obesity ( p < 0.01). No significant differences were found for GDF15 ( p = 0.62) and IL‐6 ( p = 0.17). Conclusions: Adiponectin, leptin, TNF‐α, and FGF21 show consistent directionality and may serve as robust biomarkers in obesity‐related risk profiling. Conversely, GDF15 and IL‐6 exhibit context‐dependent variability. Further prospective cohort studies are warranted to better understand these adipokines, as persons with normal weight may still be at a high risk of cardiometabolic diseases.Keywords
This publication has 73 references indexed in Scilit:
- Effect of Zinc Supplementation on Inflammatory Markers and Adipokines in Young Obese WomenBiological Trace Element Research, 2014
- A-FABP and its Association with Atherogenic Risk Profile and Insulin Resistance in Young Overweight and Obese WomenBiomarkers in Medicine, 2013
- Uric acid best predicts metabolically unhealthy obesity with increased cardiovascular risk in youth and adultsObesity, 2013
- Percent body fat is a better predictor of cardiovascular risk factors than body mass indexBrazilian Journal of Medical and Biological Research, 2012
- Interrater reliability: the kappa statisticBiochemia Medica, 2012
- The pro- and anti-inflammatory properties of the cytokine interleukin-6Biochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2011
- The Relationship between Insulin Resistance and the Cardiovascular Biomarker Growth Differentiation Factor-15 in Obese PatientsClinical Chemistry, 2011
- Increased Fibroblast Growth Factor 21 in Obesity and Nonalcoholic Fatty Liver DiseaseGastroenterology, 2010
- Is adiponectin associated with acute myocardial infarction in Iranian non obese patients?Lipids in Health and Disease, 2009
- Contour-enhanced meta-analysis funnel plots help distinguish publication bias from other causes of asymmetryJournal of Clinical Epidemiology, 2008